140 related articles for article (PubMed ID: 36150469)
1. Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form.
Ding F; Cao W; Wang R; Wang N; Li A; Wei Y; Qian S; Zhang J; Gao Y; Pang Z
J Pharm Sci; 2023 Feb; 112(2):513-524. PubMed ID: 36150469
[TBL] [Abstract][Full Text] [Related]
2. Switch between Cocrystal and Coamorphous Forms Depending on Thermal Modulation of Hot-Melt Extrusion.
Shen P; Zhang C; Hu E; Gao Y; Wei Y; Zhang J; Qian S; Heng W
Mol Pharm; 2023 Jul; 20(7):3412-3426. PubMed ID: 37253085
[TBL] [Abstract][Full Text] [Related]
3. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
Ervasti T; Aaltonen J; Ketolainen J
Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
[TBL] [Abstract][Full Text] [Related]
4. Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.
Shayanfar A; Ghavimi H; Hamishekar H; Jouyban A
J Pharm Pharm Sci; 2013; 16(4):577-87. PubMed ID: 24210065
[TBL] [Abstract][Full Text] [Related]
5. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
Huang Y; Zhang B; Gao Y; Zhang J; Shi L
J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
[TBL] [Abstract][Full Text] [Related]
6. The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State.
Bi Y; Xiao D; Ren S; Bi S; Wang J; Li F
J Pharm Sci; 2017 Oct; 106(10):3150-3155. PubMed ID: 28625724
[TBL] [Abstract][Full Text] [Related]
7. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
8. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.
Li M; Qiu S; Lu Y; Wang K; Lai X; Rehan M
Pharm Res; 2014 Sep; 31(9):2312-25. PubMed ID: 24590881
[TBL] [Abstract][Full Text] [Related]
10. Novel pharmaceutical cocrystal of lenalidomide with nicotinamide: Structural design, evaluation, and thermal phase transition study.
Wang L; Yan Y; Zhang X; Zhou X
Int J Pharm; 2022 Feb; 613():121394. PubMed ID: 34933081
[TBL] [Abstract][Full Text] [Related]
11. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
12. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S
Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225
[TBL] [Abstract][Full Text] [Related]
14. Impact of polymeric excipient on cocrystal formation via hot-melt extrusion and subsequent downstream processing.
Karimi-Jafari M; Ziaee A; Iqbal J; O'Reilly E; Croker D; Walker G
Int J Pharm; 2019 Jul; 566():745-755. PubMed ID: 31212053
[TBL] [Abstract][Full Text] [Related]
15. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
Lin HL; Zhang GC; Huang YT; Lin SY
J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
[TBL] [Abstract][Full Text] [Related]
16. Effects of Polymers on Cocrystal Growth in a Drug-Drug Coamorphous System: Relations between Glass-to-Crystal Growth and Surface-Enhanced Crystal Growth.
Luo M; Chen A; Huang C; Guo M; Cai T
Mol Pharm; 2024 Jul; 21(7):3591-3602. PubMed ID: 38818946
[TBL] [Abstract][Full Text] [Related]
17. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
18. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
Newman A; Zografi G
J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
[TBL] [Abstract][Full Text] [Related]
19. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
[TBL] [Abstract][Full Text] [Related]
20. Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.
Wang S; Heng W; Wang X; He X; Zhang Z; Wei Y; Zhang J; Gao Y; Qian S
Int J Pharm; 2020 Oct; 588():119793. PubMed ID: 32827676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
